Cyclophosphamide (CTX) Clinical Trials

5 actively recruiting trials across 1 location

Pipeline

Phase 1: 1Phase 2: 2Phase 1/2: 1

Top Sponsors

University of Illinois at Chicago1
Sun Yat-sen University1
Shanghai NK Cell Technology Co., LTD1
Peking University People's Hospital1
Institute of Hematology & Blood Diseases Hospital, China1

Indications

Cancer5
Systemic AL Amyloidosis1
Metastatic Prostate Cancer1
Chronic Myeloid Leukemia - Accelerated Phase1
Acute Myeloid Leukemia Refractory1

Other4 trials

A Phase I Study of NK042 Cell Injection in Advanced Solid Tumors

Phase 1

Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer

Phase 2

R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Phase 1/2

Rapid dFLC Response Predict CHR in AL Amyloidosis

Chicago, Illinois1 trial

Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

University of Illinois Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.